Professor of Reproductive Medicine Chief, Division of Gynecologic Oncology

MD, Mount Sinai School of Medicine, 1981
Residency, Yale New Haven Hospital, 1982-1985
Fellowship, Gynecologic Oncology, Mount Sinai Hospital, 1986-1988

telephone: 619 - 543 - 6905

Licensure: California

Certifications: National Board of Medical Examiners, 1982

American Board of Obstetrics and Gynecology, 1989

Subspecialty of Gynecologic Oncology, 1990

Patient Care: Dr. Plaxe provides a full range of consultative and treatment services for patients with gynecologic cancer. This includes surgical, radio-therapeutic and chemotherapeutic management of patients with malignancy of the vulva, vagina, cervix, corpus, fallopian tubes, ovaries and placenta (gestational trophoblastic disease).

Recent Publications:

• Plaxe SC, Braly PS, Freddo JL, McClay EF, Kirmani S, Howell SB. Profiles of young (age 30-39) and very young (age < 30) women with epithelial ovarian cancer. Obstet and Gynecol 81:651-654, 1993.
• Plaxe S, Braly P, Freddo J, McClay E, Christen R, Kim S, Kirmani S, and Howell S. Phase I trial of cisplatin in combination with gluthathione. J Gynecol Oncol 55:82-86, 1994.
• Kirmani S, Braly P, McClay E, Saltzstein S, Plaxe S, Kim S, Cates C, and Howell S. A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer. Gynecol Oncol 54:338-344, 1994.
• Plaxe S, Salzstein S. Impact of ethnicity on the incidence of high-risk endometrial cancer. Gynecol Oncol 65:8-126, 1997.
• Plaxe SC, Christen RD, O'Quigley J, Braly PS, Freddo JL, McClay E, Heath D, Howell SB. Phase I and pharmacokinetic study of intraperitoneal topotecan. Investigational New Drugs (Submitted)